EUVIMEDDécouvrir EUVIMED
CrossrefCarte d’information

Editorial: Are we facing an efficacy–effectiveness gap in pediatric psychopharmacology?

Michael H. Bloch

Journal of Child Psychology and Psychiatry · 2026-12 · 67 (12) · 1933-1936

DOI: 10.1111/jcpp.70252 ↗
RésuméRéférences bibliographiques

Résumé

The efficacy–effectiveness gap, the attenuation of benefits as interventions move from controlled trials into routine care, has received substantial focus when scrutinizing psychological interventions but has received less attention in pediatric psychopharmacology. Medication trials evaluate more than molecules: they embed systematic titration, frequent assessment, multi‐informant feedback, and adherence support. This Editorial examines whether differences between trial‐based and routine medication management create a comparable gap. Examples from stimulant treatment in the MTA, antidepressant protocols in TADS and TORDIA, and metabolic surveillance during antipsychotic treatment illustrate how dosing, follow‐up, and safety monitoring may diverge in practice, potentially altering both efficacy and the overall benefit–risk balance. Research should characterize how medications are delivered in routine care and identify which elements of trial‐based management materially improve outcomes. Disseminating evidence‐based pediatric psychopharmacology may require preserving essential medication‐management processes while recognizing constraints faced in practice.

Des connaissances adaptées à votre travail.

D’un démarrage gratuit à la Research Suite complète, en passant par la recherche bibliographique personnelle.

Voir les tarifs →

Tous les textes intégraux sont-ils inclus ?

Non. Notices, résumés et textes intégraux sont des contenus distincts. La disponibilité dépend de la source, de l’accès ouvert et de vos licences. Une offre EUVIMED ne remplace pas des droits supplémentaires auprès des éditeurs.

Voir les tarifs →